Trial site
Centro Ricerche Cliniche di Verona s.r.l.
- 120running trials
- 48closed trials
The trials here
What the 169 trials at this site are about, from their registry records.
- Conditions
- Lung cancer38 trials
- Pancreatic cancer20 trials
- Narcolepsy13 trials
- Gastric and oesophageal cancer12 trials
- Colorectal cancer9 trials
- Asthma8 trials
- Bladder cancer8 trials
- Head and neck cancer8 trials
- Kidney cancer8 trials
- Ovarian cancer8 trials
- Prostate cancer8 trials
- Sickle cell disease8 trials
- and 39 more
- Phase
- Phase 375 trials
- Phase 244 trials
- Phase 120 trials
- Phase 1/219 trials
- Phase 2/310 trials
- Phase 41 trial
- Status
- Recruiting55 trials
- Completed48 trials
- Active, not recruiting43 trials
- Not yet recruiting22 trials
- Suspended1 trial
- Lead sponsor
- AstraZeneca9 trials
- Amgen6 trials
- Astellas Pharma Global Development, Inc.6 trials
- Merck Sharp & Dohme LLC6 trials
- GlaxoSmithKline5 trials
- and 87 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Recruiting
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Not yet recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
Recruiting
Recruiting
Recruiting
Recruiting
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Recruiting
A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Recruiting
Recruiting
Active, not recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
Recruiting
Recruiting
Recruiting
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Recruiting
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Recruiting
Showing 50 of 120.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer16 recruiting
- Pancreatic cancer13 recruiting
- Narcolepsy10 recruiting
- Prostate cancer6 recruiting
- Bladder cancer5 recruiting
- Kidney cancer5 recruiting
- Gastric and oesophageal cancer4 recruiting
- Head and neck cancer4 recruiting
- Liver and biliary tract cancer4 recruiting
- Ovarian cancer4 recruiting
- Sickle cell disease4 recruiting
- Cervical cancer3 recruiting
- Chronic lymphocytic leukaemia3 recruiting
- Colorectal cancer3 recruiting
- Endometrial cancer3 recruiting
- Mantle cell lymphoma3 recruiting
- Melanoma3 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
- Diffuse large B-cell lymphoma2 recruiting
- Idiopathic pulmonary fibrosis2 recruiting
- Neuroendocrine tumours2 recruiting
- ANCA-associated vasculitis1 recruiting
- Asthma1 recruiting
- Burkitt lymphoma1 recruiting
- Chronic spontaneous urticaria1 recruiting
- COPD1 recruiting
- Follicular lymphoma1 recruiting
- Hodgkin lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Parkinson disease1 recruiting
- Rheumatoid arthritis1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
A Trial to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy.
Recruiting
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Recruiting
Active, not recruiting
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Active, not recruiting
A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Active, not recruiting
Completed
A safety study of PF-08046044/SGN-35C in adults with advanced cancers
Completed
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Active, not recruiting
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Completed
A Study of CDX-0159 in Patients With Eosinophilic Esophagitis
Active, not recruiting
Completed
Completed
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Completed
Completed
Completed
Completed
Research Study Investigating How Well NDec Works in People With Sickle Cell Disease
Completed
Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Completed
Active, not recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026